Clinical Trials Browser

Myeloproliferative Disorders × Etanercept × Clear all

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00217386 2010-09-15

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Phase 2 Completed

30 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Clinical Trials

Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes